A microfluidic platform that automates accumulation mutation with potential in mutagenic compound identification and disease modeling.
A cartilage-on-chip platform coupled to Fluigent pressure controllers to generate compressive or multi-directional mechanical stimulations to study how mechanical stimulation of the chondrocytes can help to reproduce the native articular cartilage microenvironment.
Gain insights into blood-brain barrier bbb permeability and learn more about our accurate bbb model-on-chip developed in partnership with MIT Roger D. Kamm’s group
This article presents the promise of microfluidics in enhancing the characteristics of engineered nanoparticles compared to traditional bulk production methods.
This paper highlight evaluates the flow uncertainty for Fluigent MSFC-EZ and syringe pumps and their impact on optical imaging.
This paper highlight presents a microfluidic approach with Fluigent’s Flow EZ, which can be used to create small solid lipid nanoparticles with high encapsulation rates for biologics and drugs.
